Rebalix
Amundi · sheet of 20 October 2026
Amundi · sheet of 20 October 2026ETF sheet · official issuer and register data
Amundi Core Nasdaq-100 Swap UCITS ETF Acc
UST · LU1829221024 · class UCITS ETF Acc · USD · domicile Luxembourg
Equity · United States · Large capSFDR art. 6
Index tracked: NASDAQ-100 Notional Net Total Return Index
- TER
- 0.22%+ trans. 0.00%
- Fund size
- 6.6 bn EUR
- Tracking difference
- +0.06%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Synthetic (swap)
- Income
- Accumulating
Launch 17 Jan 2019 · costs from the KID as of 2 Oct 2026 · 246 securities held · 12 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 7 Aug 2026
The Fund is an index-tracking UCITS passively managed. The investment objective of the Fund is to track both the upward and the downward evolution of the NASDAQ-100 Notional Net Total Return index (the Benchmark Index") denominated in US Dollars and representative of 100 of the largest US and international non-financial companies, while minimizing the volatility of the difference between the return of the Fund and the return of the Benchmark Index (the "Tracking Error"). The anticipated level of Tracking Error in normal market conditions is indicated in…
Performance since series start (in euro) — base 100
4 Jan 2010 → 16 Oct 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +22.3% |
| 3 years | +82.9% |
| 5 years | +104.0% |
| 10 years | +526.8% |
| Since series start | +2,054.3% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 20.31% | 21.15% | 23.62% |
| Max drawdown | −11.79% | −22.65% | −35.51% |
| Sharpe | 0.86 | 1.04 | 0.59 |
| Sortino | 1.25 | 1.53 | 0.84 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · UST · LU18292210241
RebalixUST · LU1829221024 · sheet of 20 October 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund return reconstructed by Rebalix by reinvesting distributions on each ex-date; index from the issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +20.36% | +20.77% | −0.40% |
| 2024 | +25.96% | +25.58% | +0.38% |
| 2023 | +54.91% | +54.70% | +0.21% |
| 2022 | −32.33% | −32.56% | +0.24% |
| 2021 | +26.35% | +27.24% | −0.89% |
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 1 Sept 2026 · 246 securities · top-10 weight = 46.9%
| Top holdings | Weight |
|---|---|
| 9.2% | |
| 6.2% | |
| 5.1% | |
| 4.7% | |
| 4.5% | |
| 4.3% | |
| 4.0% | |
| 3.3% | |
| 3.1% | |
| 2.7% |
Listing venues
ESMA register (FIRDS) and official exchange lists
UST · BME (Bolsa de Madrid), Borsa Italiana (ETFplus), Euronext Paris
LYMS · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
— · London Stock Exchange
+ 9 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU1829221024
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU1829221024
Series, distributions, holdings and documents refresh daily.
Sheet produced on 20 October 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · UST · LU18292210242